Is DGX or WST cheaper?

On trailing earnings, DGX is cheaper: DGX trades at a 22.79 P/E and WST at 46.84.

Which has grown faster, DGX or WST?

Over the past five years, WST grew revenue faster — DGX at a 1.76% CAGR versus WST at 6.72%.

Does DGX or WST pay a bigger dividend?

DGX yields 1.67% and WST yields 0.25% based on trailing dividends and the latest price.

Is DGX or WST more profitable?

WST runs the higher net margin — DGX at 9.08% versus WST at 16.85%.

Which has been the better investment, DGX or WST?

Over the past 10-year, WST delivered the higher annualized total return — DGX at 12.40% versus WST at 17.45%. Past performance doesn't predict future results.

Quest Diagnostics Incorporated (DGX) vs West Pharmaceutical Services, Inc. (WST)

DGX leads on 9 of 17 compared metrics.

A side-by-side comparison of Quest Diagnostics Incorporated and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

DGX

Quest Diagnostics Incorporated

$23.08B

$206.24Healthcare

WST

West Pharmaceutical Services, Inc.

$24.79B

$350.85Healthcare

Total return — DGX vs WST

growth of $100 · last 30y

DGX +5857.7%WST +4890.8%DGX compounded faster

DGX WST

DGX vs WST: by the numbers

•WST is the larger company ($24.79B vs $23.08B market cap).
•DGX trades at the lower earnings multiple (22.79 vs 46.84 P/E).
•WST converts more revenue to profit (16.85% vs 9.08% net margin).
•WST grew revenue faster over the past five years (6.72% vs 1.76% CAGR).
•DGX pays the higher dividend yield (1.67% vs 0.25%).

Which is better, DGX or WST?

Metric tally: DGX 9 · WST 8

It depends on what you're optimizing for:

ValueDGX(lower P/E)

GrowthWST(faster 5Y revenue CAGR)

IncomeDGX(higher dividend yield)

QualityWST(higher ROIC)

Metrics side by side

Valuation

Metric	DGX	WST
P/E ratio	22.79●	46.84
Forward P/E	17.67●	36.63
P/S ratio	2.05●	7.89
P/B ratio	3.14●	8.49
PEG ratio	1.43●	33.99
EV / EBITDA	14.27●	29.94
FCF yield	5.74%●	1.80%

Profitability

Metric	DGX	WST
Gross margin	33.23%	36.24%●
Operating margin	14.31%	20.67%●
Net margin	9.08%	16.85%●
ROE	13.90%	18.15%●
ROIC	8.43%	13.62%●

Dividends

Metric	DGX	WST
Dividend yield	1.67%●	0.25%
Payout ratio	38.78%	12.88%

Growth (annualized)

Metric	DGX	WST
Revenue CAGR (5Y)	1.76%	6.72%●
EPS CAGR (5Y)	-3.65%	7.85%●
FCF CAGR (5Y)	-8.51%	8.32%●
Total return CAGR (5Y)	12.14%●	-0.26%

Frequently asked

Which is better, DGX or WST?: It depends on your goal. value: DGX (lower P/E); growth: WST (faster 5Y revenue CAGR); income: DGX (higher dividend yield); quality: WST (higher ROIC). Across all compared metrics, DGX leads 9 to 8.
Is DGX or WST cheaper?: On trailing earnings, DGX is cheaper: DGX trades at a 22.79 P/E and WST at 46.84.
Which has grown faster, DGX or WST?: Over the past five years, WST grew revenue faster — DGX at a 1.76% CAGR versus WST at 6.72%.
Does DGX or WST pay a bigger dividend?: DGX yields 1.67% and WST yields 0.25% based on trailing dividends and the latest price.
Is DGX or WST more profitable?: WST runs the higher net margin — DGX at 9.08% versus WST at 16.85%.
Which has been the better investment, DGX or WST?: Over the past 10-year, WST delivered the higher annualized total return — DGX at 12.40% versus WST at 17.45%. Past performance doesn't predict future results.

Go deeper

Full DGX analysis Full WST analysis Interactive comparison tool

Dig into the metrics

Quest Diagnostics P/E ratio West Pharmaceutical Services P/E ratio Quest Diagnostics dividend yield West Pharmaceutical Services dividend yield Quest Diagnostics ROE West Pharmaceutical Services ROE Quest Diagnostics operating margin West Pharmaceutical Services operating margin Quest Diagnostics revenue growth West Pharmaceutical Services revenue growth Quest Diagnostics free cash flow West Pharmaceutical Services free cash flow

Quest Diagnostics & West Pharmaceutical Services appear in these rankings

Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.